125 related articles for article (PubMed ID: 6454336)
21. T-lymphocyte subpopulations in rheumatoid arthritis. II. Definition by monoclonal antibodies.
Pfreundschuh M; Michel H; Parino G; Gram N; Stock C; Gause A; Hunstein W
Z Rheumatol; 1981; 40(6):245-9. PubMed ID: 6460396
[TBL] [Abstract][Full Text] [Related]
22. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
23. Cell surface CD28 levels define four CD4+ T cell subsets: abnormal expression in rheumatoid arthritis.
Salazar-Fontana LI; Sanz E; Mérida I; Zea A; Sanchez-Atrio A; Villa L; Martínez-A C; de la Hera A; Alvarez-Mon M
Clin Immunol; 2001 May; 99(2):253-65. PubMed ID: 11318597
[TBL] [Abstract][Full Text] [Related]
24. Origin of defective T lymphocyte-suppressor activating factor interaction in patients with rheumatoid arthritis.
Keystone EC; Budz-Tymkewycz S; Toews M; Lau C
Clin Exp Immunol; 1987 Jul; 69(1):48-56. PubMed ID: 2958193
[TBL] [Abstract][Full Text] [Related]
25. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
Mathsson L; Lampa J; Mullazehi M; Rönnelid J
Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
[TBL] [Abstract][Full Text] [Related]
26. [The clinico-prognostic assessment of DNA antibodies and antinuclear factors in rheumatoid arthritis patients].
Dormidontov EN; Okhapkina OV; Riazantseva TA
Ter Arkh; 1991; 63(8):96-9. PubMed ID: 1792630
[TBL] [Abstract][Full Text] [Related]
27. Evidence for B cell activation in patients with active rheumatoid arthritis.
Youinou PY; Irving WL; Shipley M; Hayes J; Lydyard PM
Clin Exp Immunol; 1984 Jan; 55(1):91-8. PubMed ID: 6607144
[TBL] [Abstract][Full Text] [Related]
28. Immune complexes in early arthritis. L Detection of immune complexes before rheumatoid arthritis is definite.
Jones VE; Jacoby RK; Wallington T; Holt P
Clin Exp Immunol; 1981 Jun; 44(3):512-21. PubMed ID: 6976861
[TBL] [Abstract][Full Text] [Related]
29. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
30. Mononuclear phagocyte system Fc-receptor function in patients with seropositive rheumatoid arthritis.
Lobatto S; Breedveld FC; Camps JA; Pauwels EK; Westedt ML; Daha MR; van Es LA
Clin Exp Immunol; 1987 Mar; 67(3):461-6. PubMed ID: 3111762
[TBL] [Abstract][Full Text] [Related]
31. Splenic reticuloendothelial function in patients with active rheumatoid arthritis.
Gordon PA; Davis P; Russell AS; Coates JE; Rothwell RS; LeClercq SM
J Rheumatol; 1981; 8(3):490-3. PubMed ID: 6974780
[TBL] [Abstract][Full Text] [Related]
32. Immune functional impairment in patients with clinical abnormalities and silicone breast implants.
Vojdani A; Campbell A; Brautbar N
Toxicol Ind Health; 1992; 8(6):415-29. PubMed ID: 7570622
[TBL] [Abstract][Full Text] [Related]
33. Elevation in anti-Proteus antibodies in patients with rheumatoid arthritis from Bermuda and England.
Subair H; Tiwana H; Fielder M; Binder A; Cunningham K; Ebringer A; Wilson C; Hudson MJ
J Rheumatol; 1995 Oct; 22(10):1825-8. PubMed ID: 8991977
[TBL] [Abstract][Full Text] [Related]
34. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.
Paulus HE; Wiesner J; Bulpitt KJ; Patnaik M; Law J; Park GS; Wong WK
J Rheumatol; 2002 Dec; 29(12):2513-20. PubMed ID: 12465144
[TBL] [Abstract][Full Text] [Related]
35. Loss of suppressor T cell function and circulating immune complexes in chronic active liver diseases.
Hotta R; Kuriki J; Kakumu S
Clin Exp Immunol; 1981 Nov; 46(2):375-81. PubMed ID: 6461458
[TBL] [Abstract][Full Text] [Related]
36. Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease.
Kawanishi H; Tavassolie H; MacDermott RP; Sheagren JN
Gastroenterology; 1981 Mar; 80(3):510-7. PubMed ID: 6450078
[TBL] [Abstract][Full Text] [Related]
37. [T cell proliferative response and antibody formation to citrullinated collagen type II in patients with rheumatoid arthritis].
Tian X; Zhao Y; Li ZG
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):673-6. PubMed ID: 19595060
[TBL] [Abstract][Full Text] [Related]
38. Vaccination with selected synovial T cells in rheumatoid arthritis.
Chen G; Li N; Zang YC; Zhang D; He D; Feng G; Ni L; Xu R; Wang L; Shen B; Zhang JZ
Arthritis Rheum; 2007 Feb; 56(2):453-63. PubMed ID: 17265481
[TBL] [Abstract][Full Text] [Related]
39. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
[TBL] [Abstract][Full Text] [Related]
40. Impaired release of a T-cell specific suppressor factor in rheumatoid arthritis.
Lau C; Budz-Tymkewycz S; Ramsden M; Lee P; Keystone EC
Clin Exp Immunol; 1985 Sep; 61(3):489-95. PubMed ID: 3878238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
